{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:52:17Z","timestamp":1787755937933,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,14]]},"DOI":"10.7759\/cureus.73658","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:37:01Z","timestamp":1731573421000},"source":"Crossref","is-referenced-by-count":1,"title":["Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: Outcomes From a Tertiary Cancer Care Center in India"],"prefix":"10.7759","author":[{"given":"Mukurdipi","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawani","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwetal","family":"Sonvane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.45.379","article-title":"Malignant mesothelioma: global incidence and relationship with asbestos","volume":"45","author":"Bianchi C","year":"2007","unstructured":"Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 2007, 45:379-87. 10.2486\/indhealth.45.379","journal-title":"Ind Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100737","article-title":"Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies - an evidence-based review","volume":"45","author":"Ray MD","year":"2021","unstructured":"Ray MD, Dhall K. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies - an evidence-based review. Curr Probl Cancer. 2021, 45:100737. 10.1016\/j.currproblcancer.2021.100737","journal-title":"Curr Probl Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta P","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007, 18:985-90. 10.1093\/annonc\/mdl345","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/030089160308900307","article-title":"Clinical presentation of peritoneal mesothelioma","volume":"89","author":"Acherman YI","year":"2003","unstructured":"Acherman YI, Welch LS, Bromley CM, Sugarbaker PH. Clinical presentation of peritoneal mesothelioma. Tumori. 2003, 89:269-73. 10.1177\/030089160308900307","journal-title":"Tumori"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl428","article-title":"A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan TD","year":"2007","unstructured":"Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007, 18:827-34. 10.1093\/annonc\/mdl428","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000567","article-title":"Peritoneal metastases from adrenal cortical carcinoma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"102","author":"Sugarbaker PH","year":"2016","unstructured":"Sugarbaker PH. Peritoneal metastases from adrenal cortical carcinoma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Tumori. 2016, 102:588-92. 10.5301\/tj.5000567","journal-title":"Tumori"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.03.001","article-title":"Peritoneal surface oncology: a progress report","volume":"32","author":"Gonz\u00e1lez-Moreno S","year":"2006","unstructured":"Gonz\u00e1lez-Moreno S. Peritoneal surface oncology: a progress report. Eur J Surg Oncol. 2006, 32:593-6. 10.1016\/j.ejso.2006.03.001","journal-title":"Eur J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp AJ","year":"2001","unstructured":"Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev. 2001, 27:365-74. 10.1053\/ctrv.2001.0232","journal-title":"Cancer Treat Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.22.14_suppl.9729","article-title":"Peritoneal mesothelioma treated by cytoreductive surgery and intra peritoneal hyperthermic perfusion: Clinical and translational study","volume":"22","author":"Deraco M","year":"2004","unstructured":"Deraco M, Kusamura S, Baratti D, Casali P, Gronchi A, Zaffaroni N. Peritoneal mesothelioma treated by cytoreductive surgery and intra peritoneal hyperthermic perfusion: Clinical and translational study. J Clin Oncol. 2004, 22:9729. 10.1200\/jco.2004.22.14_suppl.9729","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.05.041","article-title":"Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study","volume":"13","author":"Brigand C","year":"2006","unstructured":"Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, Glehen O. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol. 2006, 13:405-12. 10.1245\/ASO.2006.05.041","journal-title":"Ann Surg Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21050","article-title":"Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care","volume":"98","author":"McQuellon R","year":"2008","unstructured":"McQuellon R, Gavazzi C, Piso P, Swain D, Levine E. Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care. J Surg Oncol. 2008, 98:300-5. 10.1002\/jso.21050","journal-title":"J Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21322","article-title":"Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis","volume":"100","author":"Schmidt C","year":"2009","unstructured":"Schmidt C, Moritz S, Rath S, et al.. Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol. 2009, 100:297-301. 10.1002\/jso.21322","journal-title":"J Surg Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet P","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996, 82:359-74. 10.1007\/978-1-4613-1247-5_23","journal-title":"Cancer Treat Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker PH","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995, 221:29-42. 10.1097\/00000658-199501000-00004","journal-title":"Ann Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien PA","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al.. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009, 250:187-96. 10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21177","article-title":"Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience","volume":"99","author":"Chua TC","year":"2009","unstructured":"Chua TC, Yan TD, Morris DL. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol. 2009, 99:109-13. 10.1002\/jso.21177","journal-title":"J Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis J","year":"2015","unstructured":"Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A, Efstathiou E, Giassas S. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol. 2015, 22:1570-5. 10.1245\/s10434-014-4157-9","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23749","article-title":"Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis","volume":"110","author":"Ahmed S","year":"2014","unstructured":"Ahmed S, Stewart JH, Shen P, Votanopoulos KI, Levine EA. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. J Surg Oncol. 2014, 110:575-84. 10.1002\/jso.23749","journal-title":"J Surg Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/BF02524350","article-title":"Atypical lipomatous tumor\/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations","volume":"11","author":"Kooby DA","year":"2004","unstructured":"Kooby DA, Antonescu CR, Brennan MF, Singer S. Atypical lipomatous tumor\/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2004, 11:78-84. 10.1007\/BF02524350","journal-title":"Ann Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/0-387-28274-2_16","article-title":"Determination of asbestos exposure by pathology and clinical history","author":"Gibbs AR","unstructured":"Gibbs AR. Determination of asbestos exposure by pathology and clinical history. Malignant Mesothelioma. Springer-Verlag, 259-66. 10.1007\/0-387-28274-2_16"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: a multicenter study on 81 cases","volume":"21","author":"Manzini VP","year":"2010","unstructured":"Manzini VP, Recchia L, Cafferata M, et al.. Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol. 2010, 21:348-53. 10.1093\/annonc\/mdp307","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181c50cde","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry","volume":"20","author":"Helm CW","year":"2010","unstructured":"Helm CW, Richard SD, Pan J, et al.. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010, 20:61-9. 10.1111\/IGC.0b013e3181c50cde","journal-title":"Int J Gynecol Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan TD","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al.. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009, 27:6237-42. 10.1200\/JCO.2009.23.9640","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21708","article-title":"Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique","volume":"106","author":"Kusamura S","year":"2006","unstructured":"Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006, 106:1144-53. 10.1002\/cncr.21708","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander HR Jr","year":"2013","unstructured":"Alexander HR Jr, Bartlett DL, Pingpank JF, et al.. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013, 153:779-86. 10.1016\/j.surg.2013.01.001","journal-title":"Surgery"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.150","article-title":"Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy","volume":"21","author":"Feldman AL","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF, et al.. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003, 21:4560-7. 10.1200\/JCO.2003.04.150","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm137","article-title":"Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer","volume":"18","author":"Bijelic L","year":"2007","unstructured":"Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol. 2007, 18:1943-50. 10.1093\/annonc\/mdm137","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/312878-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-for-peritoneal-mesothelioma-outcomes-from-a-tertiary-cancer-care-center-in-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:37:03Z","timestamp":1731573423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/312878-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-for-peritoneal-mesothelioma-outcomes-from-a-tertiary-cancer-care-center-in-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.73658","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}